740 related articles for article (PubMed ID: 20411997)
1. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.
Nicasio AM; Eagye KJ; Nicolau DP; Shore E; Palter M; Pepe J; Kuti JL
J Crit Care; 2010 Mar; 25(1):69-77. PubMed ID: 19427167
[TBL] [Abstract][Full Text] [Related]
3. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
Eagye KJ; Nicolau DP; Kuti JL
Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
[TBL] [Abstract][Full Text] [Related]
4. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
Shorr AF; Combes A; Kollef MH; Chastre J
Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
[TBL] [Abstract][Full Text] [Related]
5. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
6. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
7. Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population.
McMillian WD; Bednarik JL; Aloi JJ; Ahern JW; Crookes BA
J Trauma; 2010 Oct; 69(4):861-5. PubMed ID: 20938272
[TBL] [Abstract][Full Text] [Related]
8. Repeat bronchoalveolar lavage to guide antibiotic duration for ventilator-associated pneumonia.
Mueller EW; Croce MA; Boucher BA; Hanes SD; Wood GC; Swanson JM; Chennault SK; Fabian TC
J Trauma; 2007 Dec; 63(6):1329-37; discussion 1337. PubMed ID: 18212657
[TBL] [Abstract][Full Text] [Related]
9. Does bronchoalveolar lavage enhance our ability to treat ventilator-associated pneumonia in a trauma-burn intensive care unit?
Wahl WL; Franklin GA; Brandt MM; Sturm L; Ahrns KS; Hemmila MR; Arbabi S
J Trauma; 2003 Apr; 54(4):633-8; discussion 638-9. PubMed ID: 12707523
[TBL] [Abstract][Full Text] [Related]
10. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
Warren DK; Shukla SJ; Olsen MA; Kollef MH; Hollenbeak CS; Cox MJ; Cohen MM; Fraser VJ
Crit Care Med; 2003 May; 31(5):1312-7. PubMed ID: 12771596
[TBL] [Abstract][Full Text] [Related]
11. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
12. [Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study].
Fekih Hassen M; Ayed S; Ben Sik Ali H; Gharbi R; Marghli S; Elatrous S
Ann Fr Anesth Reanim; 2009 Jan; 28(1):16-23. PubMed ID: 19097848
[TBL] [Abstract][Full Text] [Related]
13. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
[TBL] [Abstract][Full Text] [Related]
14. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia.
Shorr AF; Tabak YP; Gupta V; Johannes RS; Liu LZ; Kollef MH
Crit Care; 2006; 10(3):R97. PubMed ID: 16808853
[TBL] [Abstract][Full Text] [Related]
15. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia.
Agbaht K; Diaz E; Muñoz E; Lisboa T; Gomez F; Depuydt PO; Blot SI; Rello J
Crit Care Med; 2007 Sep; 35(9):2064-70. PubMed ID: 17581489
[TBL] [Abstract][Full Text] [Related]
16. Clinical and economic consequences of ventilator-associated pneumonia.
Amin A
Clin Infect Dis; 2009 Aug; 49 Suppl 1():S36-43. PubMed ID: 19619020
[TBL] [Abstract][Full Text] [Related]
17. The impact of ventilator-associated pneumonia on the Canadian health care system.
Muscedere JG; Martin CM; Heyland DK
J Crit Care; 2008 Mar; 23(1):5-10. PubMed ID: 18359415
[TBL] [Abstract][Full Text] [Related]
18. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
19. Inappropriate antibiotic use due to decreased compliance with a ventilator-associated pneumonia computerized clinical pathway: implications for continuing education and prospective feedback.
Wilde AM; Nailor MD; Nicolau DP; Kuti JL
Pharmacotherapy; 2012 Aug; 32(8):755-63. PubMed ID: 23307523
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of monotherapy in the treatment of Pseudomonas ventilator-associated pneumonia in patients with trauma.
Magnotti LJ; Schroeppel TJ; Clement LP; Swanson JM; Bee TK; Maish GO; Minard G; Zarzaur BL; Fischer PE; Fabian TC; Croce MA
J Trauma; 2009 Apr; 66(4):1052-8; discussion 1058-9. PubMed ID: 19359914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
